HIV trials recruiting in Maryland

All HIV trials nationally

Cities in Maryland

Recruiting trials in Maryland

• 1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
  NCT05608421 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · Maryland: Baltimore
• A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV
  NCT07392372 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Baltimore
• A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
  NCT05719441 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Maryland: Baltimore
• A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women
  NCT06703060 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · Maryland: Baltimore
• A Setting Focus Overdose Prevention Intervention
  NCT05320835 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
  NCT04139304 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
  NCT07143968 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants
  NCT07525544 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Maryland: Baltimore
• Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
  NCT04941274 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Maryland: Bethesda
• Alcohol Research in HIV: Relapse Prevention
  NCT05163301 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
  NCT00114647 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · Maryland: Bethesda
• Cabotegravir-Hormone PK/PD Interactions for HIV Prevention
  NCT07672717 · Phase: Phase 1 · Ages: 19 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
  NCT00789009 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Bethesda
• Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
  NCT05663502 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
  NCT05907759 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
  NCT04499053 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study
  NCT05652478 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Maryland: Bethesda
• Education and Employment Support for HIV Prevention in Young Adults (ENSPIRE)
  NCT06096324 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 24 Years · Sex: All (male and female) · Maryland: Baltimore
• Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
  NCT06624839 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Male · Maryland: Baltimore
• Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
  NCT06691243 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Baltimore
• Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers
  NCT07349758 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Expanding HOPE Liver
  NCT07778459 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
  NCT05419024 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · Maryland: Bethesda
• Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
  NCT07473778 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
  NCT06263426 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy
  NCT06819176 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Maryland: Bethesda
• Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
  NCT00039689 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
  NCT00029445 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · Maryland: Bethesda
• Menopausal HT for Women Living With HIV (HoT)
  NCT06856174 · Phase: Phase 4 · Ages: 40 Years to 60 Years · Sex: Female · Maryland: Baltimore
• Natural History Study of Kaposi Sarcoma
  NCT06375122 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
  NCT01730131 · Phase: Not specified · Ages: 2 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
  NCT01419561 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Natural History of KSHV-Associated Multicentric Castleman s Disease
  NCT04968288 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Bethesda
• PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
  NCT04303117 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Maryland: Bethesda
• Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
  NCT04052022 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · Maryland: Bethesda
• Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)
  NCT06501781 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 88 Years · Sex: All (male and female) · Maryland: Baltimore
• Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
  NCT06052618 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
  NCT05389423 · Phase: Phase 1 · Ages: 18 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
  NCT04902443 · Phase: Phase 1 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Maryland: Bethesda
• Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
  NCT07308886 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers
  NCT03878121 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Bethesda
• Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
  NCT05580458 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Bethesda
• Screen2Prevent (S2P)
  NCT07728123 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 24 Years · Sex: All (male and female) · Maryland: Baltimore
• Skeletal Muscle Energetics and Fatiguability in Older Individuals
  NCT04142047 · Phase: Not specified · Ages: 60 Years to 90 Years · Sex: All (male and female) · Maryland: Baltimore
• Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
  NCT00006518 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Strategies to AchieVe Viral Suppression for Youth With HIV
  NCT06886971 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 30 Years · Sex: All (male and female) · Maryland: Baltimore
• Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
  NCT00001281 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
  NCT07040319 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 45 Years · Sex: Female · Maryland: Baltimore
• Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
  NCT06103370 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore, Frederick
• The Collaborative Care PrTNER Study
  NCT06585631 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 29 Years · Sex: Male · Maryland: Baltimore
• The LD Lync Study - Natural History Study of Lipodystrophy Syndromes
  NCT03087253 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Maryland: Bethesda
• Thinking and Memory Problems in People With HIV
  NCT01875588 · Phase: Not specified · Ages: 18 Years to 110 Years · Sex: All (male and female) · Maryland: Bethesda
• Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
  NCT05470491 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Trial of Ixazomib for Kaposi Sarcoma
  NCT04305691 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
  NCT07293559 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Maryland: Baltimore
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
  NCT02140255 · Phase: Phase 1, Phase 2 · Ages: Up to 48 Hours · Sex: All (male and female) · Maryland: Baltimore
• Viral Load in Blood and Lymph Tissues in People Living With HIV
  NCT00001316 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · Maryland: Bethesda